DE3380125D1 - Assay for the free portion of substances in biological fluids - Google Patents

Assay for the free portion of substances in biological fluids

Info

Publication number
DE3380125D1
DE3380125D1 DE8383301463T DE3380125T DE3380125D1 DE 3380125 D1 DE3380125 D1 DE 3380125D1 DE 8383301463 T DE8383301463 T DE 8383301463T DE 3380125 T DE3380125 T DE 3380125T DE 3380125 D1 DE3380125 D1 DE 3380125D1
Authority
DE
Germany
Prior art keywords
assay
substances
biological fluids
free portion
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383301463T
Other languages
German (de)
English (en)
Inventor
John Cecil Charlton
John Edward Midgley
Terence Arthur Wilkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Ltd
Original Assignee
Amersham International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10529163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3380125(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham International PLC filed Critical Amersham International PLC
Application granted granted Critical
Publication of DE3380125D1 publication Critical patent/DE3380125D1/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE8383301463T 1982-03-22 1983-03-16 Assay for the free portion of substances in biological fluids Expired DE3380125D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8208273 1982-03-22

Publications (1)

Publication Number Publication Date
DE3380125D1 true DE3380125D1 (en) 1989-08-03

Family

ID=10529163

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383301463T Expired DE3380125D1 (en) 1982-03-22 1983-03-16 Assay for the free portion of substances in biological fluids

Country Status (4)

Country Link
US (1) US4839299A (enExample)
EP (1) EP0089806B1 (enExample)
JP (1) JPS58172551A (enExample)
DE (1) DE3380125D1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1944283A (en) * 1982-08-27 1984-03-29 Ekins Roger Philip Measurement of analyte concentration
GB8404843D0 (en) * 1984-02-24 1984-03-28 Amersham Int Plc Free analyte assay
DE3415818C1 (de) * 1984-04-27 1985-04-18 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Verfahren zur Bestimmung freier Substanzen in biologischen Fluessigkeiten
EP0165669A1 (en) * 1984-05-04 1985-12-27 Corning Glass Works Improved method of measuring free ligand
GB2158578B (en) * 1984-05-08 1988-03-09 Farmos Group Ltd Immunometric method for the determination of a hapten
AU560779B2 (en) * 1985-01-24 1987-04-16 Quidel Assay for drugs of abuse
EP0218309B1 (en) * 1985-10-04 1995-11-15 Diagnostic Products Corporation Method for measuring free ligands in biological fluids
FR2598514B1 (fr) * 1986-05-12 1988-07-01 Commissariat Energie Atomique Procede de dosage immunologique des hormones thyroidiennes t3 et/ou t4 utilisant la thyroglobuline
DE3624464A1 (de) * 1986-07-19 1988-01-28 Boehringer Mannheim Gmbh Verfahren zum nachweis eines analyten sowie hierfuer geeignetes mittel
DE3626468A1 (de) * 1986-08-05 1988-02-11 Hoechst Ag Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten
DE3727238A1 (de) * 1987-08-14 1989-02-23 Henning Berlin Gmbh Immunologisches bestimmungsverfahren zur bestimmung von hapteneigenschaften aufweisenden freien substanzen
GB8800419D0 (en) * 1988-01-08 1988-02-10 Amersham Int Plc Method for measuring free fraction of ligands in biological fluids
EP0467078B1 (en) * 1990-07-18 1996-05-08 Abbott Laboratories An analyte-subtitute reagent for use in specific binding assay methods, devices and kits
US5464749A (en) * 1991-07-22 1995-11-07 Bayer Corporation Immunoassay of free substances in biological fluids
IT1254858B (it) * 1992-04-14 1995-10-11 Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.
DE4214922C2 (de) * 1992-05-06 1996-06-13 Brahms Diagnostica Gmbh Verfahren zur quantitativen Bestimmung des Anteils der freien Form eines Schilddrüsenhormon-Liganden in einer biologischen Flüssigkeit und Kit zur Durchführung eines solchen Verfahrens
FR2706618B1 (fr) * 1993-06-11 1995-09-01 Bio Merieux Dispositif pour le dosage d'haptènes et son utilisation.
DE19504198A1 (de) * 1995-02-09 1996-08-14 Behringwerke Ag Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
CA2283597C (en) 1998-10-02 2008-02-05 Ortho-Clinical Diagnostics, Inc. Reduced cortisol conjugates
ATE349989T1 (de) 2003-05-22 2007-01-15 Medoc Ltd Sonde zur thermischen stimulation und verfahren dafür

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960492A (en) * 1974-05-31 1976-06-01 Nuclear Diagnostics, Inc. Method for determining an index of binding protein content of blood
US4311690A (en) * 1978-06-20 1982-01-19 Damon Corporation Test set and method for the determination of free hormones
US4292296A (en) * 1978-09-12 1981-09-29 Baxter Travenol Laboratories, Inc. Diagnostic method
US4222744A (en) * 1978-09-27 1980-09-16 Becton Dickinson & Company Assay for ligands
US4366143A (en) * 1979-09-24 1982-12-28 Amersham International Public Limited Company Assay for the free portion of substances in biological fluids
US4426453A (en) * 1980-09-18 1984-01-17 Amersham International Limited Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
WO1983003306A1 (en) * 1982-03-19 1983-09-29 Roger Philip Ekins Method and composition for free ligand assays

Also Published As

Publication number Publication date
JPS58172551A (ja) 1983-10-11
EP0089806A1 (en) 1983-09-28
JPH0326346B2 (enExample) 1991-04-10
US4839299A (en) 1989-06-13
EP0089806B1 (en) 1989-06-28

Similar Documents

Publication Publication Date Title
DE3380125D1 (en) Assay for the free portion of substances in biological fluids
DE3070420D1 (en) A method for determining the free portion of substances in biological fluids
DE3366234D1 (en) Sampling device for use in the sampling of biological fluids
GB8431875D0 (en) Determination of biological fluids
EP0112721A3 (en) Assay technique
GB8622855D0 (en) Determining biological substance
GB8310650D0 (en) Immobilization of biological materials
EP0119622A3 (en) Integral element for biological reaction and process for the preparation thereof
DE3373543D1 (en) Assay
GB8708949D0 (en) Mixing fluids
DE3274017D1 (en) Assay and use
EP0153783A3 (en) Method for the quantitative determination of calcium in biological fluids through direct potentiometry
GB8307120D0 (en) Liquids
GB8400807D0 (en) Substrate for fluoroassay of biological fluids
NZ223914A (en) Assay for fructosamine in body fluids
DE3369386D1 (en) Assay for the free portion of substances in biological fluids
GB8607699D0 (en) Mixing fluids
ZA805898B (en) Assay for the free portion of substances in biological fluids
EP0103139A3 (en) Reagent composition for immunoassay and immunoassay using the same
GB2125547B (en) Simultaneous immunoassay of two or more substances
GB8603470D0 (en) Introducing substances into liquids
GB8609285D0 (en) Liquid flow analysis
GB2173416B (en) Improvements in or relating to the handling of liquids
GB8307254D0 (en) Mixing liquids together
ZA832078B (en) Novel dna and use thereof

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: AMERLITE DIAGNOSTICS LTD., AMERSHAM, BUCKINGHAMSHI

8328 Change in the person/name/address of the agent

Free format text: LEDERER, F., DIPL.-CHEM. DR. KELLER, G., DIPL.-BIOL.UNIV. DR.RER.NAT., 8000 MUENCHEN RIEDERER FRHR. VON PAAR ZU SCHOENAU, A., DIPL.-ING., PAT.-ANWAELTE, 8300 LANDSHUT

8331 Complete revocation